miR-19a/b and MeCP2 repress reciprocally to regulate multidrug resistance in gastric cancer cells.
miR-19a/b and MeCP2 repress reciprocally to regulate multidrug resistance in gastric cancer cells.
复制标题
miR-19a/b和MeCP2相互抑制调节胃癌细胞的多药耐药性
DOI:
10.3892/ijmm.2018.3581
复制
发表时间:
2018-07
影响因子:
5.4
通讯作者:
Shi Y
中科院分区:
文献类型:
--
作者:
Zhu F;Wu Q;Ni Z;Lei C;Li T;Shi Y
Despite the improvement in gastric cancer (GC) treatment, multidrug resistance (MDR) is still a significant reason for chemotherapy failure. Our previous studies have demonstrated that miR-19a/b upregulation directly promoted MDR in GC cells. However, the exact regulation and the potential molecule mechanisms have not been fully clarified. In this study, we found that miR-19a/b was directly involved in 5-aza-2′-deoxycytidine (5-Aza-dC) induced MDR of GC cells. Mechanically, demethylation of miR-19a/b repressed methyl CpG binding protein 2 (MeCP2) expression via direct binding at the 3′-untranslated regions, which then alleviated the inhibitory effects of MeCP2 on miR-19a/b expression. Thus, the mutual regulatory network sustains preservation of the expression levels of miR-19a/b. We further demonstrated that miR-19a/b expression was inversely correlated to MeCP2 expression in GC tissues. These data showed an intimate interplay among miR-19a/b methylation, MeCP2 activity, and MDR, revealing a potential therapeutic target for GC.
登录
查看更多内容
DOI:
10.1111/j.1440-1746.2008.05666.x
发表时间:
2009-04-01
影响因子:
4.1
作者:
Guo, Junming;Miao, Ying;Wang, Yanjun
通讯作者:
Wang, Yanjun
影响因子:
9.7
作者:
Fang, JY;Lu, R;Chen, YX
通讯作者:
Chen, YX
影响因子:
6.4
作者:
Wada, Rie;Akiyama, Yoshimitsu;Yuasa, Yasuhito
通讯作者:
Yuasa, Yasuhito
影响因子:
14.9
作者:
Tili E;Michaille JJ;Liu CG;Alder H;Taccioli C;Volinia S;Calin GA;Croce CM
通讯作者:
Croce CM
影响因子:
3.7
作者:
Hashimoto Y;Akiyama Y;Yuasa Y
通讯作者:
Yuasa Y